Bernadette Connaughton, Director: Halozyme Therapeutics HALO Sell · Filed 25/11/12

Trade details

Type: Insider sale
Amount: $136,960
Shares · price: 2,000 sh · $68.48 a share
Held after: 42,952 sh
Stock: Halozyme Therapeutics HALO
Person: Bernadette ConnaughtonDirector
Trade date: 25/11/10
Filed: 25/11/12
Days to filing: 2 days

Sold 4.4% of holdings

Share of holding sold: 4.4%

Halozyme Therapeutics trades, last 26 weeks

What else happened in Halozyme Therapeutics around then

Filed or reported within 30 days of the trade day · 25/10/11~25/12/10

Bernadette Connaughton's recent trades

Bernadette ConnaughtonDirector
Planned sale10b5-1 planHalozyme Therapeutics
Planned sale10b5-1 plan
Halozyme Therapeutics
HALO
$167.7K
1,626 sh
$167.7K
Filed 08/10
Traded 08/10
Bernadette ConnaughtonDirector
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$107.6K
1,625 sh
$107.6K
Filed 06/02
Traded 06/01
Bernadette ConnaughtonDirector
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$103.2K
1,625 sh
$103.2K
Filed 05/05
Traded 05/01
Bernadette ConnaughtonDirector
Planned sale10b5-1 planHalozyme Therapeutics
Planned sale10b5-1 plan
Halozyme Therapeutics
HALO
$310.3K
4,875 sh
$310.3K
Filed 05/01
Traded 05/01
Bernadette ConnaughtonDirector
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$140.5K
2,000 sh
$140.5K
Filed 01/06
Traded 01/05